Price T Rowe Associates Inc. MD Decreases Stake in Vericel Co. (NASDAQ:VCEL)
Price T Rowe Associates Inc. MD lowered its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 2.9% during the fourth quarter, HoldingsChannel reports. The fund owned 29,479 shares of the biotechnology company’s stock after selling 868 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Vericel were worth $1,619,000 as of […]
